Complement C5a, TGF-β1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion

Circulation

Volumn 95, Issue 3, 1997, Pages 684-692

  Birdsall, Holly H ^a,f   Green, David M ^a,f   Trial, JoAnn ^a,f   Youker, Keith A ^b,f   Burns, Alan R ^c,f   MacKay, Charles R ^e   LaRosa, Gregory J ^e   Hawkins, Hal K ^d   Smith, C Wayne ^c,f   Michael, Lloyd H ^b,f   Entman, Mark L ^b,f   Rossen, Roger D ^a,f  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b Methodist Hospital   (United States)

^c Texas Children's Hospital   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

^e MILLENNIUM PHARMACEUTICALS INC   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

blood cells; immune system; ischemia; leukocytes; reperfusion

Indexed keywords

COMPLEMENT COMPONENT C5A; MONOCYTE CHEMOTACTIC PROTEIN 1; POLYCLONAL ANTIBODY; TECHNETIUM 99M; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; COMPLEMENT SYSTEM; CONTROLLED STUDY; DOG; HEART MUSCLE; HEART MUSCLE REPERFUSION; IMMUNE RESPONSE; ISCHEMIC HEART DISEASE; ISOTOPE LABELING; LEUKOCYTE MIGRATION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL;

EID: 16944366340     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.95.3.684     Document Type: Article

References (11)

1. Cowan MJ, Reichenbach D, Turner P, Thostenson C. Cellular response of the evolving myocardial infarction after therapeutic coronary artery reperfusion. Hum Pathol. 1991;22:154-163.
2. Entman ML, Smith CW. Postperfusion inflammation: a model for reaction to injury in cardiovascular disease. Cardiovasc Res. 1994;28:1301-1311.
3. Maroko PR, Carpenter CB, Chiarello M, Fishbein MC, Radvany P, Kostman JD, Hale SL. Reduction by cobra venom factor of myocardial necrosis after coronary artery occlusion. J Clin Invest. 1978;61:661-670.
4. Crawford MH, Grover FL, Kolb WP, McMahan CA, O'Rourke RA, McManus LM, Pinckard RN. Complement and neutrophil activation in the pathogenesis of ischemic myocardial injury. Circulation. 1988;78:1449-1458.
5. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science. 1990;249:146-151.
6. Dreyer WJ, Smith CW, Michael LH, Rossen RD, Hughes BJ, Entman ML, Anderson DC. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Circ Res. 1989;65:1751-1762.
7. Dreyer WJ, Michael LH, Nguyen T, Smith CW, Anderson DC, Entman ML, Rossen RD. Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ Res. 1992;71:1518-1524.
8. Sommers HM, Jennings RB. Experimental acute myocardial infarction: histologic and histochemical studies of early myocardial infarcts induced by temporary or permanent occlusion of a coronary artery. Lab Invest. 1964;13:1491-1503.
9. Dreyer WJ, Smith CW, Michael LH, West MS, Smith CW, Rothlein R, Rossen RD, Anderson DC, Entman ML. Neutrophil accumulation in ischemic canine myocardium. Circulation. 1991;84:400-411.
10. Engler RL, Dahlgren MD, Morris DD, Peterson MA, Schmid-Schonbein GW. Role of leukocytes in response to acute myocardial ischemia and refiow in dogs. Am J Physiol. 1986;251:H314-H323.
11. Ito BR, Schmid-Schonbein G, Engler RL. Effects of leukocyte activation on myocardial vascular resistance. Blood Cells. 1990;16:145-163.